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Evaluation of a system of structured, pro-active
care for chronic depression in primary care:
a randomised controlled trial
Marta Buszewicz1*, Mark Griffin1, Elaine M McMahon1, Jennifer Beecham3, Michael King2
Abstract
Background: People with chronic depression are frequently lost from effective care, with resulting psychological,
physical and social morbidity and considerable social and financial societal costs. This randomised controlled trial will
evaluate whether regular structured practice nurse reviews lead to better mental health and social outcomes for
these patients and will assess the cost-effectiveness of the structured reviews compared to usual care.
The hypothesis is that structured, pro-active care of patients with chronic depression in primary care will lead to a
cost-effective improvement in medical and social outcomes when compared with usual general practitioner (GP)
care.
Methods/Design: Participants were recruited from 42 general practices throughout the United Kingdom. Eligible
participants had to have a history of chronic major depression, recurrent major depression or chronic dsythymia
confirmed using the Composite International Diagnostic Interview (CIDI). They also needed to score 14 or above
on the Beck Depression Inventory (BDI-II) at recruitment.
Once consented, participants were randomised to treatment as usual from their general practice (controls) or the
practice nurse led intervention. The intervention includes a specially prepared education booklet and a compre-
hensive baseline assessment of participants’ mood and any associated physical and psycho-social factors, followed
by regular 3 monthly reviews by the nurse over the 2 year study period. At these appointments intervention parti-
cipants’ mood will be reviewed, together with their current pharmacological and psychological treatments and any
relevant social factors, with the nurse suggesting possible amendments according to evidence based guidelines.
This is a chronic disease management model, similar to that used for other long-term conditions in primary care.
The primary outcome is the BDI-II, measured at baseline and 6 monthly by self-complete postal questionnaire. Sec-
ondary outcomes collected by self-complete questionnaire at baseline and 2 years include social functioning, qual-
ity of life and data for the economic analyses. Health service data will be collected from GP notes for the 24
months before recruitment and the 24 months of the study.
Discussion: 558 participants were recruited, 282 to the intervention and 276 to the control arm. The majority were
recruited via practice database searches using relevant READ codes.
Trial registration: ISRCTN36610074
Background
Major depression is very common, with a UK prevalence
at any time of at least 5%, with another 5% having
milder episodes [1]. The majority of people with depres-
sion in the UK are treated within general practice, it
being the third most common reason for consultations
[2]. Despite evidence that over half of all patients with
an acute depressive episode will have a recurrence, and
that the risk of further recurrences increases greatly
with further episodes, there appears to be little consis-
tency in the longer-term management of the disorder,
and significant psychological, physical and social mor-
bidity in this group [3,4]. In addition, a significant min-
ority of patients (around 18-25%) will have chronic
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depressive disorders [3]. Chronicity is associated with
greater likelihood of psychological, physical and social
morbidity, an earlier death from all causes, and the
health and social costs are considerable [5,6]. Incom-
plete recovery increases the risk of relapse and may pre-
dict long-term outcome more accurately than baseline
severity [7,8]. Evidence also shows that the earlier a
recurrence is detected, the better and speedier the
recovery, but currently many such patients may be
inadequately treated and have little or no specific fol-
low-up in primary care [9,4].
The rationale behind this trial was the treatment of
depression as a potentially chronic or recurring pro-
blem, using regular pro-active contact and follow-up of
at risk patients by practice nurses, supported by general
practitioners (GPs) in their practices [10]. There is evi-
dence in favour of such strategies from the USA, but
they have not yet been formally researched in the UK
[11]. Work from the USA has shown that organised,
enhanced care can have a beneficial effect both on the
outcomes of patients with acute major depression and
also those with a high risk of recurrence [12,13]. How-
ever, there is also some evidence that the effect of such
a coordinated approach can lapse over time and recent
work has indicated that a longer-term approach may be
indicated, particularly for those at risk of chronic diffi-
culties [14,15].
The form of organised or enhanced care being
trialled has elements in common with the manage-
ment of other chronic diseases in general practice,
such as asthma, diabetes and hypertension [10]. Evi-
dence based guidelines identify similar elements of
patient care for a range of chronic conditions, includ-
ing a well-defined care plan, patient education, sched-
uled follow-ups, review of outcome and concordance,
and targeted use of specialist consultation or referral
[16]. Practice nurses are in an excellent position to
provide such an approach and there is evidence that
they can do this very well, often communicating parti-
cularly effectively with patients in the management of
chronic problems [17].
Feasibility Work
A 6-month pilot feasibility study was conducted in three
general practices in North London, with 35 patients ran-
domised by practice. The aim was to test out the inter-
vention and the measures to be used in a full trial and
to conduct qualitative, in-depth interviews with 12
patients who completed the intervention. Participants
responded well to this practice nurse intervention, parti-
cularly valuing contact with someone who they per-
ceived as a ‘normal, mature person drawing on their
own experience’, rather than with a mental health pro-
fessional. Practice nurses had more time than GPs, gave
helpful, practical advice and a sense that they were
interested in patients’ problems [18].
This pilot study demonstrated that it was feasible to
recruit sufficient eligible participants willing to take part
and that they would be able to complete the relevant
questionnaires. The feasibility study also indicated that
the chances of contamination between intervention and
control patients within a practice was low, as the major-
ity of the patient contact in the intervention was carried
out by nurses who were very unlikely have consultations
with the control patients to discuss their mental health
symptoms, although they might carry out other practice
nurse consultations for physical health reasons. We
therefore decided to randomise by patient within prac-
tices in the main trial, rather than carrying out a cluster
randomisation design.
Methods/Design
This is a randomised controlled trial, with randomisa-
tion by patient within practices. The comparison is
between ‘GP usual care’ (control arm), and a ‘structured
care’ approach involving regular follow-up by practice
nurses (intervention arm) in addition to GP usual care,
for patients with a history of recurrent or chronic
depression.
Participants were recruited from 38 general practices
which are members of the Medical Research Council’s
General Practice Research Framework (MRC GPRF), a
framework of over 1,000 general practices throughout
the United Kingdom. An additional 4 practices were
recruited, having received details of the study and
expressing an interest in participating (2 from the UK’s
Primary Care Research Network and 2 from local con-
tacts). See Figure 1 for the distribution of practices
nationally.
Within practices potential trial participants were
recruited in the following ways:
• General practitioner and practice nurse recall of
potential participants
Location of participating practices in ProCEED
Greater London (3)
Midlands (7)
Northern Ireland (4)
North of England (10)
Scotland (1)
South East England (10)
South West England (7)
Figure 1 Location of participating practices.
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• Practice database searches by READ code (a clinical
classification system widely used in UK primary care)
and/or anti-depressant prescriptions [19].
• Practice leaflets and posters in the waiting-room
encouraging patients to come forward
For the full inclusion and exclusion criteria see below.
This was a pragmatic trial, so we aimed to keep the
exclusion criteria to a minimum. Patients who expressed
suicidal ideas were not excluded, but the practice nurses
were given clear guidelines about their management and
at what point it would be appropriate to communicate
with the GP if they were concerned about a patient.
Inclusion criteria
(i) Men and women aged 18 and over
(ii) Two or more documented episodes of depression
within the previous 3 years
(These may have been separate episodes with a period
of well-being in-between, or a documented history of
chronic depression. In either case some treatment, either
pharmacological or psychological or both should have
been instigated, although it may not have been
successful)
(iii) Evidence of recurrent and/or chronic depression
via the Composite International Diagnostic Interview
[20]
(iv) Baseline Beck Depression Inventory-II score of 14
or above (indicating at least mild depression) [21].
(We selected this inclusion criterion to cover patients
with chronic dysthymia and those with residual symp-
toms from major depression, as there is much evidence
that this group is at particular risk of recurrence and
poor outcomes)
(v) Sufficient English to be able to complete self-report
questionnaires
Exclusion criteria
(i) Current psychotic symptoms
(ii) Impaired cognitive function
(iii) Incapacitating alcohol or drug dependence
All identified patients were sent a letter from the GP
and practice nurse on practice headed notepaper,
enclosing a study information leaflet and a reply slip
and asking them to indicate whether they would like to
meet with the practice research nurse to discuss the
study in more detail. Those who declined were asked to
give an indication of their reasons for this on the reply
slip.
Those who met with the nurse and still wanted to
take part after discussing the study were assessed for
eligibility using the Composite International Diagnostic
Interview (CIDI) questionnaire and given a Beck
Depression Inventory (BDI-II) questionnaire to complete
[20,21]. Those who fulfilled the inclusion criteria and
gave fully informed consent had their details passed to
an independent computerised telephone/internet based
randomisation centre. The nurse was able to let partici-
pants know their randomisation outcome at the baseline
interview. All eligible consented participants in both
groups were asked to complete the baseline question-
naires in a quiet place in the practice centre before they
left, with the aim of achieving a high response rate.
Randomisation
We used the MRC computerised telephone randomisa-
tion service in Aberdeen, which provides an efficient
automated 24-hour service and the choice of randomisa-
tion by telephone or Internet in each case. Randomisa-
tion was at the patient level within each practice, using
a block design to maintain a balance of numbers in the
control and intervention groups.
Trial Intervention
The trial intervention aims to combine management
strategies already familiar to primary care staff, but in a
concerted and consistent manner [22]. It was found to
be well within the expertise of the practice nurses
involved in the feasibility study. The model is similar in
some ways to that used in the longer-term care of
patients with asthma or diabetes in primary care. Com-
ponents include:
Recall system
Recall systems have been set up within the participating
practices based on the practice computer and managed
by the practice research nurse, who is responsible for
contacting the intervention patients. If participants fail
to attend a review appointment they are asked to make
another appointment. If they fail to attend again, they
are contacted for review at the next time point.
Clinical review
For all intervention participants the practice research
nurse undertook a baseline assessment, asking about
current mood, social circumstances, current treatment
(medication and/or psychological therapy), and any side-
effects or queries. Participants were given a specially
written educational booklet about depression and its
treatment at this initial appointment. There is evidence
that appropriate patient education materials can be
helpful as part of an integrated approach’ [11-13]. This
patient booklet was written specifically for the patients
in this study and outlines current evidence based think-
ing about the treatment of depression.
The nurses answered participants’ questions about
current or past treatments and checked their concor-
dance with the treatments they were currently receiving,
clarifying any reasons for poor concordance. If there
Buszewicz et al. BMC Psychiatry 2010, 10:61
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were current symptoms of depression, alternative or
additional treatments were discussed. These could be
pharmacological, psychological or social, with the ratio-
nale and evidence for any of these being made clear,
both in the background literature given to patients and
in their discussion with the nurses. Social factors, which
could be contributing to the chronicity of patients’
depression, were explored (e.g. social isolation, low phy-
sical activity, unemployment, finance, housing) and
appropriate advice given or referrals to other agencies
made. The importance of patient choice and active par-
ticipation in this process and in the treatments selected
was emphasised.
A joint management plan was then formulated
between the nurses and each of their patients and
reviewed during subsequent appointments, together
with a review of how the patient was feeling and any
progress made with previous goals set. We aimed to
teach participants how to monitor their own mental
state and to have a sense of possible predictors of
relapse. Evidence from other studies indicates this can
be helpful [15].
Timing of intervention appointments
Intervention patients were seen for a baseline assess-
ment, after one month and then two months later - i.e.
three times over the initial 3 months of the study. The
purpose of having the initial appointments more clo-
sely spaced was to allow sufficient time for the nurses
to get to know the patient well and to formulate a
clear management plan together. After this, the reviews
for intervention patients took place 3 monthly for the
remainder of the 24 month trial period, but could be
more frequent if there were any significant clinical
concerns about the patients’ mood. Such a flexible
approach was found helpful in a two-year study with
good outcomes, and the arrangements were left to the
discretion of the nurse [15]. If patients were keeping
well, it was considered appropriate to conduct this
review over the telephone, with evidence from other
studies showing this to be feasible [23]. Nevertheless,
we asked the nurses to have face-to-face contact with
participants every few appointments. If nurses were
concerned about a patient, they were asked to discuss
them with the relevant GP, who might also see the
patient if indicated.
Treatment as usual
During the 24 month study period the participants in
the control arm had ‘treatment as usual’ and continued
to see their GP on request, with no restrictions placed
on any interventions which the GP might recommend.
It was stipulated that the control arm participants
should not see the practice research nurse for any men-
tal health intervention, although they might see her for
physical health problems.
Research nurse training sessions
The research team provided 4 full days training for all
the participating practice nurses as follows:
• Day 1: covered the procedures required to recruit
participants to the trial, checking their eligibility (includ-
ing conducting the CIDI interview) and conducting the
computerised randomisation.
• Day 2: covered the procedures and information
required for the intervention appointments, including
assessment of a patient’s level of depression, details of
evidence based pharmacological and psychological treat-
ments for depression, and the importance of considering
relevant social factors.
Brief training was given in problem solving techniques
to help patients address some of these difficulties.
• Day 3: A further day’s training was arranged after 6
months for the nurses to discuss some of their clinical
cases, and in particular to focus on ways of working
with their more complicated or resistant clients. Brief
training was given in the use of simple motivational
interviewing techniques to use with patients finding it
difficult to make any changes in their lives [24].
All the information from the three training days was
written in a manual for the nurses to take away with
them, and they were regularly updated with information
about potentially useful resources available. The nurses
were also encouraged to ensure that they maintained
access to up to date information about appropriate local
voluntary and other organisations which they could
encourage patients to contact where appropriate.
• Day 4: This training session was for the procedures
required for the final assessment at 24 months, includ-
ing conducting a further CIDI interview (see further
details below).
Clinical Supervision sessions
Each nurse was assigned a member of the research team
as a ‘clinical supervisor’ (two of these were general prac-
titioners with a special interest in mental health and one
was a clinical psychologist). Nurses had regular tele-
phone contact (generally every 3-4 months) with their
supervisors throughout the trial period. The format used
was a general review, giving nurses the opportunity to
discuss their intervention cases and any concerns they
might have, as well as the supervisor making suggestions
about possible changes in approach or treatment where
appropriate. Nurses could also contact their clinical
supervisor in between if they had a particular concern
or query about a patient.
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Outcome measures
The primary outcome measure is the Beck Depression
Inventory (BDI-II). The BDI-II is a reliable and well-
validated measure for measurement of the severity of
depression and monitoring its clinical outcome, which
has been used in many primary care studies [21]. It will
also be involved in the assessment of cost-effectiveness
as part of the health economic analysis.
Secondary outcomes (table 1)
(a) Depression-Free Days: These will be assessed in two
ways. They will be calculated using BDI-II assessment
scores following the method of Lave et al. [25]. This will
then be compared with patients’ self-completed records
of which days they felt they were significantly depressed,
to see how a continuous form of data collection com-
pares with a statistical method for assessing persistence
of depression. (Our feasibility data indicates that
patients will be prepared to keep such on-going
records).
(b) Social Functioning: This will be measured using
the Work and Social Activity Scale (WASAS). This is a
well-established, brief questionnaire, which we will use
to assess participants’ difficulties with physical and social
functioning associated with their depression [26]. It has
been validated for use in primary care populations with
depression.
(c) Frequency of Depressive Episodes: Will be col-
lected using the CIDI questionnaire [20]. This instru-
ment is frequently used in psychiatric epidemiological
studies and has been modified to allow us to collect
diagnostic data on trial participants as regards their
depression using DSM-IV criteria for the 36 months
before recruitment as well as the 24 months of the trial.
(d) Patient personality factors: Participants are asked
at baseline to complete the Standardised Assessment of
Personality - Abbreviated Scale (SAPAS), a brief mea-
sure of personality variables developed for use in pri-
mary care [27].
(e) Quality of life: This will be measured by the Euro-
quol EQ-5 D, which will generate scores for the cost-
utility analysis [28].
(f) Resource use and costs: Data on all services used
and productivity losses over a retrospective 3-month
period will be collected using a modified version of the
Client Service Receipt Inventory (CSRI), which has been
used in numerous economic evaluations, including in
primary care populations [29].
(g) Practice service data: The research nurses will also
be asked to count the number of GP attendances and
home visits, practice nurse contacts, referrals for psy-
chological therapy and prescriptions for psychotropic
medication for all participants for the 24 months before
recruitment and the 24 months of the trial.
In order to maintain blindness the final research
assessment will be carried out by a different person.
This may be another nurse at the practice, a MRC
GPRF regional training nurse or a Mental Health
Research Network Clinical Studies Officer. All partici-
pants will be asked at the outset of the final assessment
not to reveal their trial arm allocation. As a check on
potential bias, each practitioner assessing outcome will
be asked to record which trial arm they think each
patient they have assessed was in, to see whether the
probability of a correct ‘guess’ is greater than chance.
Depression-free Days recorded in Mood Diaries
Following successful piloting in the feasibility study all
participants were asked to complete regular mood dia-
ries, indicating for each day whether they had been
depressed or not. This was something that had been
both feasible and acceptable for the six months of the
pilot study, but proved overly time-consuming and
onerous for many participants in the full trial, with
the response rate being quite poor after the first
3 months.
We therefore reduced the requirement to completion
of the diaries for 50% of the project time. An algorithm
was constructed, with the 2 years of the trial follow-up
divided into eight 3 month portions and participants
randomly allocated to receiving the diaries for four of
these time periods. Random allocation of diary periods
means that data can be imputed for the whole trial per-
iod and used as a patient record of their depression free
days, as well to validate the scores calculated using the
BDI-II scores by the method of Lave et al. [25].
The questionnaires listed were self-completed, apart
from the CIDI which was administered by the research
nurses in the practices, who also collected the service
usage data. In order to ensure good response rates,
Table 1 Frequency of measuring outcome measures
BDI-
II
WASAS CIDI
(24 months)
SAPAS EQ-
5D
CSRI Service
Data
(24
months)
Baseline √ √ √ √ √ √ √
3
months*
√
6
months
√
12
months
√
18
months
√
24
months
√ √ √ √ √ √
* We had initially planned to collect BDI-II questionnaires 3 monthly, but
decided this was too onerous for participants and risked a poor response rate,
so this was altered to 6 monthly from the 6 months time-point
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participants were given a booklet with all the self-com-
pletion questionnaires to fill in when they attended the
surgery at baseline and at 24 months for their
assessments.
BDI-II questionnaires and mood diaries during the
intervening two years were posted to all participants
with a self-addressed envelope enclosed for their reply.
A reminder letter and copy of the questionnaire was
sent after two weeks if participants did not respond. If
they failed to return the primary outcome measure, the
BDI-II, they were telephoned by the practice research
nurse to prompt them to return the questionnaire.
Proposed sample size
We conducted two sample size calculations - for both a
4 and 5 point difference in the primary outcome mea-
sure, the BDI-II. In order to detect a 4-point difference
on the BDI-II (assuming a pooled standard deviation of
11.0) at 90% power and the 5% level of significance, the
required sample size was 318. To meet the objectives of
the economic analysis (see details below) data from a
previous trial comparing GP care and talking therapies
showed a sample size of approximately 200 in each
study arm would be required, rising to 534 using an
estimated 25% drop-out rate [30].
To take account of practice clustering we used an
intra-class correlation (ICC) of 0.02 which, given an esti-
mated 12 to 14 patients recruited per practice, inflated
our sample size to 630 from 47 practices (see table 2
below). We considered this to be a suitable ICC given
that a primary care trial with the BDI as the outcome
for GPs using cognitive behavioural techniques with
their patients gave an ICC of 0.13 [31].
A 4 point difference in BDI score would be a conser-
vative result and is the smallest difference we would
expect to achieve. In a previous trial of counselling in
primary care the results showed a 5 point difference in
outcome which is equivalent to a clinically important
treatment effect of 0.5 [31].
We therefore repeated the same calculations for a dif-
ference in outcome of 5 points on the BDI, which indi-
cated that we would need 423 participants from as few
as 32 practices recruiting 12 to 14 patients each. This
would also provide sufficient power for a cost-effective-
ness analysis using this outcome.
Planned analyses
All data will be double entered, using a reputable data
entering service, blind as to participant group.
A description of baseline characteristics will be made
between those randomised to the control and interven-
tion groups.
All outcome analyses will include individuals in their
randomised arm (intention to treat). Initial descriptive
statistics will be used to summarise the differences in
outcome between the two groups. We will present
means and standard deviations for normally distributed,
continuous variables and medians, with inter-quartile
ranges, for those not normally distributed. Categorical
outcomes will be presented as frequencies and percen-
tages within each of the categories.
Observations at each time point on the same indivi-
dual will not be independent so a repeated measures
generalised linear model approach will be used [32].
This will also allow adjustments to be made for the nat-
ural clustering inherent in the study design. Continuous
outcomes, which are measured at baseline and at the
end of follow-up, will be analysed using analysis of cov-
ariance (ANCOVA) to adjust for any differences in base-
line values [33]. Results will be presented as adjusted
differences in means with 95% confidence intervals and
associated p-values. Categorical outcomes will be com-
pared using logistic regression and summarised by com-
paring the group values of the odds ratios for each
outcome using 95% confidence intervals and associated
p-values. Statistical techniques will be used to assess the
impact of potential missing data [34]. Multiple imputa-
tion using a predictive model based approach will be
used to impute missing values [35]. No interim or sub-
group analyses are planned.
The impact of clustering by GP and/or nurse will be
investigated using multi-level modelling. This will
ensure that estimated standard errors of the treatment
effect will be adjusted for the cluster effects.
Table 2 Four Point Difference in BDI
ICC Design effect* Total sample size Number of practices required
Required With 25% drop-out
0 1 400 534 40
0.01 1.09 436 581 44
0.02 1.18 472 630 47
0.03 1.27 508 678 51
0.04 1.36 544 725 54
0.05 1.45 580 774 58
*Design effect = 1 + (n-1) × ICC, based on clusters with 10 individuals per cluster.
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Economic Analysis
The economic evaluation will be conducted from two
perspectives: (i) focusing on service costs (public expen-
diture) and (ii) a societal perspective including service
costs, productivity losses and informal care inputs. Ser-
vice costs will be calculated by attaching unit costs to
data reported on the CSRI using, wherever possible,
national unit costs from publicly-available sources or
estimated using an equivalent approach [36,37]. The ser-
vice use patterns and associated costs for the two groups
will be compared at each time point and changes over
time will be analysed using standard non-parametric
techniques.
Cost-effectiveness will be assessed using the net-bene-
fit statistic, a reformulation of the cost-effectiveness
decision rule that does not rely on cost-effectiveness
ratios with their associated statistical problems [38].
This will allow the cost-effectiveness analysis to be for-
mulated within a standard regression type framework
[39]. Inclusion of the EQ-5 D allows a cost-utility
Figure 2 Consort Diagram: Recruitment and treatment group allocation.
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analysis and a cost-effectiveness analysis will link total
costs with the primary clinical outcome measure
(change in the level of depression using the Beck
Depression Inventory-II) and the number of depression-
free days (see above). A cost-consequence analysis will
explore the relationship between cost, characteristics,
needs and outcome measures [40]. All analyses will take
into account cluster effects in practices and sensitivity
analyses will check assumptions made in the cost calcu-
lations and analyses.
Interim results - Participant recruitment
3,293 people in the 42 participating practices were iden-
tified as potentially suitable to take part in the trial
using the methods described above and were sent letters
from their practices giving them information about the
study and inviting them to come and discuss this in
more detail with the practice research nurses. Most of
these potential participants (2,974) were identified via
database searches, and only small numbers via GP or
nurse identification (188) or self-referral in response to
practice posters (34). See Figure 2, the Consort Diagram.
Of the 3,293 people initially approached, 959 (29%)
expressed an interest in attending for the interview and
828 (25%) actually attended. Following the recruitment
interview and assessment 558 people were found eligible
and agreed to take part in the trial. Using the compu-
terised randomisation system 276 participants were allo-
cated to the Control Group and 282 to the Intervention
Group. 240 people were found to be ineligible at the
recruitment interview stage, 157 because they did not
score at least 14 on the BDI-II and 83 because they
were ineligible on the CIDI.
Use of Vouchers
Because the response rate for the primary outcome mea-
sure the BDI-II went down from 72% to 66% between
the 3 months and 6 months follow-up points, there was
a concern that this would persist or get worse at later
time points and impair the validity of the study results.
We therefore decided to reduce the frequency of the
BDI-II questionnaires to 6 monthly (see frequency table;
table 1 above) and to incentivise completion by sending
participants who had returned questionnaires a £ 10
High Street voucher which can be used at many stores
nationally. Ethical approval was granted for sending of
the vouchers, which represented a reimbursement to the
participants for time spent completing and returning the
questionnaires.
At 12 months the BDI-II response rate was 67%,
which was still not optimal. We therefore changed our
approach at the 18 month time-point and sent the vou-
chers at the same time as the BDI-II questionnaires, as
a recent Cochrane review indicated that this may further
improve the response rate [41].
Ethical Approval
This trial received ethical approval from the Royal Free
Hospital & Medical School Research Ethics Committee
on the 21st February 2007 - REC reference number 07/
Q0501/15. Amendments were approved in July 2007,
November 2008 and May 2009.
Discussion
This RCT recruited 558 participants within the UK over
a 9-month period. By far the most effective recruitment
method was to use structured searches of general prac-
tice databases for potential participants, who were then
approached through a letter, signed by a GP and nurse
at the practice, which told them about the study and
asked if they were interested in taking part. Much smal-
ler numbers of participants were recruited through GP
or nurse recommendations or the leaflets or posters in
the surgery encouraging self-referral.
The numbers recruited should allow us to demonstrate
a clinically significant effect if the intervention is to be
helpful in this population with its significant psychologi-
cal and functional morbidity. We will review the effect of
sending participants vouchers at the 12, 18 and 24 month
time-points to see whether this has had the desired effect
of improving the questionnaire return rate.
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